Gary Hattersley, CHIEF SCIENTIFIC OFFICER at Nuvation Bio Inc. (NUVB), sold 200,000 shares at $5.02 ($1.0M) on 2025-10-27, disclosed to the SEC on 2025-10-29.
Scheduled sale ($1.0M) by CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.02 | 100,000 | $502K | 50.0% |
| 2 | $5.02 | 100,000 | $502K | 50.0% |
| Total | $5.02 avg | 200,000 | $1.0M | 100% |
| Filing → |
| RDUS | SELL | 2015-11-13 | $426K | — | Filing → |
| RDUS | SELL | 2015-11-05 | $933K | — | Filing → |
| RDUS | SELL | 2015-10-27 | $735K | — | Filing → |